Long-Term Inhibition of Rho-Kinase Suppresses Left Ventricular Remodeling After Myocardial Infarction in Mice
- 11 May 2004
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 109 (18) , 2234-2239
- https://doi.org/10.1161/01.cir.0000127939.16111.58
Abstract
Background— Rho-kinase has been implicated as an important regulator of inflammatory responses mediated by cytokines and chemokines. Because proinflammatory cytokines play a critical role in left ventricular (LV) remodeling after myocardial infarction (MI), we examined whether long-term blockade of Rho-kinase suppresses LV remodeling in a mouse model of MI in vivo. Methods and Results— Mice underwent ligation of the left coronary artery and were treated with a Rho-kinase inhibitor, fasudil (100 mg · kg −1 · d −1 in tap water), for 4 weeks, starting 1 day after the surgery. At 4 weeks, LV infarct size was histologically comparable between the 2 groups. LV cavity dilatation and dysfunction evaluated by echocardiography were significantly suppressed in the fasudil group ( P P 2 , TGF-β 3 , and macrophage migration inhibitory factor, was upregulated in the noninfarcted LV in the control group and was significantly suppressed in the fasudil group (both P P Conclusions— These results indicate that Rho-kinase is substantially involved in the pathogenesis of LV remodeling after MI associated with upregulation of proinflammatory cytokines, suggesting a therapeutic importance of the molecule for the prevention of post-MI heart failure.Keywords
This publication has 25 references indexed in Scilit:
- Long-Term Treatment With a Specific Rho-Kinase Inhibitor Suppresses Cardiac Allograft Vasculopathy in MiceCirculation Research, 2004
- Long-Term Inhibition of Rho-Kinase Suppresses Neointimal Formation After Stent Implantation in Porcine Coronary Arteries: Involvement of Multiple MechanismsArteriosclerosis, Thrombosis, and Vascular Biology, 2004
- Long-Term Inhibition of Rho-Kinase Suppresses Angiotensin II–Induced Cardiovascular Hypertrophy in Rats In VivoCirculation Research, 2003
- Pioglitazone, a Peroxisome Proliferator–Activated Receptor-γ Agonist, Attenuates Left Ventricular Remodeling and Failure After Experimental Myocardial InfarctionCirculation, 2002
- Changes in Extracellular Matrix and in Transforming Growth Factor Beta Isoforms After Coronary Artery Ligation in RatsJournal of Molecular and Cellular Cardiology, 2001
- Involvement of Rho-kinase in hypertensive vascular disease: a novel therapeutic target in hypertensionThe FASEB Journal, 2001
- Cellular and Molecular Mechanisms of Coronary Artery SpasmJapanese Circulation Journal, 2000
- Myocyte hypertrophy: the long and winding RhoA’dJournal of Clinical Investigation, 1999
- Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscleNature Genetics, 1996
- Expression of transforming growth factor-β2 and β3 mRNAs and proteins in the developing chicken embryoDifferentiation, 1994